• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PET/CT can predict therapy response in some lymphomas


PET/CT can predict therapy response in some lymphomas

A Johns Hopkins University study added to the growing base of evidence showing that quantitative PET/CT can predict the response to treatment in patients with bone metastases from lymphomas.

Dr. Behnaz Goudarzi and colleagues retrospectively reviewed PET/CT reports from 1100 patients with lymphoma. They identified a subset of 28 patients with aggressive lymphoma and bone lesions with high FDG uptake and compared standardized uptake values and Hounsfield unit values for these lesions before and after therapy. Evidence of treatment response came in the form of significant decrease in FDG uptake and increase in tumor density. They presented their findings at the 2007 RSNA meeting .

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.